CFM
GILD icon

Cornerstone Financial Management’s Gilead Sciences GILD Stock Holding History

Cornerstone Financial Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
166
+70
+73% +$9.22K 0.02% 262
2026
Q1 		$13.4K Buy
96
+22
+30% +$3.08K 0.01% 260
2025
Q4 		$9.08K Buy
+74
New +$8.99K 0.01% 307

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Financial Management's GILD Position: Q2 2026 in Review

Cornerstone Financial Management increased its Gilead Sciences (GILD) stake by 73% in Q2 2026, buying an estimated $9.22K and bringing the position to 166 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #262.

Cornerstone Financial Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cornerstone Financial Management held 166 shares of Gilead Sciences worth $21K as of Q2 2026.
  • Cornerstone Financial Management bought 70 Gilead Sciences shares in Q2 2026, an estimated $9.22K.
  • Gilead Sciences made up 0.02% of Cornerstone Financial Management's portfolio in Q2 2026, its #262 holding.
  • Cornerstone Financial Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.